Advancing diagnostic innovation with custom lyophilised formats

As diagnostics continue to shift toward decentralised and point-of-care (POC) settings, the demand for stable, easy-to-use reagent formats has never been higher. Biopharma Group CDMO scientists specialise in delivering custom lyophilised solutions designed to meet the unique needs of diagnostic developers worldwide.

In-house expertise and facilities mean that both lyobead and lyocake formats are available, providing flexible formats that integrate seamlessly into a range of devices, everything from multi-chamber cartridges to flat reaction chambers. Our solutions support a broad array of applications, including qPCR, RT-LAMP, isothermal amplification, and molecular diagnostics.

What sets Biopharma Group apart is a fully collaborative approach. The diagnostics team will work closely with customers at every stage, from feasibility and R&D batches to validation and full commercial production. The team brings technical expertise in formulation, lyophilisation, and analytical characterisation, ensuring each reagent product delivers the required performance and stability.

Flexible manufacturing capabilities mean Biopharma Group can accommodate the changing needs of diagnostic innovators, whether supporting early-stage development, navigating scale-up, or responding to shifting market demands. Importantly, all diagnostics CDMO services are fully supported with robust quality and regulatory support, helping de-risk projects and accelerate time to market.

Biopharma Group is proud to partner with diagnostic leaders to bring reliable, high-performing solutions to patients and healthcare providers worldwide. Whether you’re looking for custom lyobeads, lyocakes, or end-to-end technical collaboration, Biopharma Group is here to help turn your vision into reality.

Discover more from your lyo CDMO partners today.

More information online